114 related articles for article (PubMed ID: 25994795)
1. The Importance of Quasi-4D Path-Integrated Dose Accumulation for More Accurate Risk Estimation in Stereotactic Liver Radiotherapy.
Taylor ML; Yeo UA; Supple J; Keehan S; Siva S; Kron T; Pham D; Haworth A; Franich RD
Technol Cancer Res Treat; 2016 Jun; 15(3):428-36. PubMed ID: 25994795
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of dosimetric misrepresentations from 3D conventional planning of liver SBRT using 4D deformable dose integration.
Yeo UA; Taylor ML; Supple JR; Siva S; Kron T; Pham D; Franich RD
J Appl Clin Med Phys; 2014 Nov; 15(6):4978. PubMed ID: 25493523
[TBL] [Abstract][Full Text] [Related]
3. Investigation of four-dimensional (4D) Monte Carlo dose calculation in real-time tumor tracking stereotatic body radiotherapy for lung cancers.
Chan MK; Kwong DL; Ng SC; Tam EK; Tong AS
Med Phys; 2012 Sep; 39(9):5479-87. PubMed ID: 22957615
[TBL] [Abstract][Full Text] [Related]
4. Optimization of normalized prescription isodose selection for stereotactic body radiation therapy: conventional vs robotic linac.
Ding C; Solberg TD; Hrycushko B; Xing L; Heinzerling J; Timmerman RD
Med Phys; 2013 May; 40(5):051705. PubMed ID: 23635253
[TBL] [Abstract][Full Text] [Related]
5. Impact of IMRT and leaf width on stereotactic body radiotherapy of liver and lung lesions.
Dvorak P; Georg D; Bogner J; Kroupa B; Dieckmann K; Pötter R
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1572-81. PubMed ID: 15817364
[TBL] [Abstract][Full Text] [Related]
6. Tumor control probability and the utility of 4D vs 3D dose calculations for stereotactic body radiotherapy for lung cancer.
Valdes G; Robinson C; Lee P; Morel D; Low D; Iwamoto KS; Lamb JM
Med Dosim; 2015; 40(1):64-9. PubMed ID: 25542785
[TBL] [Abstract][Full Text] [Related]
7. The impact of respiratory motion and treatment technique on stereotactic body radiation therapy for liver cancer.
Wu QJ; Thongphiew D; Wang Z; Chankong V; Yin FF
Med Phys; 2008 Apr; 35(4):1440-51. PubMed ID: 18491539
[TBL] [Abstract][Full Text] [Related]
8. Accumulated Delivered Dose Response of Stereotactic Body Radiation Therapy for Liver Metastases.
Swaminath A; Massey C; Brierley JD; Dinniwell R; Wong R; Kim JJ; Velec M; Brock KK; Dawson LA
Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):639-48. PubMed ID: 26461006
[TBL] [Abstract][Full Text] [Related]
9. Radiobiological modeling of two stereotactic body radiotherapy schedules in patients with stage I peripheral non-small cell lung cancer.
Huang BT; Lin Z; Lin PX; Lu JY; Chen CZ
Oncotarget; 2016 Jun; 7(26):40746-40755. PubMed ID: 27203739
[TBL] [Abstract][Full Text] [Related]
10. Spatiotemporal fractionation schemes for liver stereotactic body radiotherapy.
Unkelbach J; Papp D; Gaddy MR; Andratschke N; Hong T; Guckenberger M
Radiother Oncol; 2017 Nov; 125(2):357-364. PubMed ID: 28951010
[TBL] [Abstract][Full Text] [Related]
11. Tumor motion changes in stereotactic body radiotherapy for liver tumors: an evaluation based on four-dimensional cone-beam computed tomography and fiducial markers.
Shimohigashi Y; Toya R; Saito T; Ikeda O; Maruyama M; Yonemura K; Nakaguchi Y; Kai Y; Yamashita Y; Oya N; Araki F
Radiat Oncol; 2017 Mar; 12(1):61. PubMed ID: 28335794
[TBL] [Abstract][Full Text] [Related]
12. Radiobiological impact of dose calculation algorithms on biologically optimized IMRT lung stereotactic body radiation therapy plans.
Liang X; Penagaricano J; Zheng D; Morrill S; Zhang X; Corry P; Griffin RJ; Han EY; Hardee M; Ratanatharathom V
Radiat Oncol; 2016 Jan; 11():10. PubMed ID: 26800883
[TBL] [Abstract][Full Text] [Related]
13. 4D VMAT, gated VMAT, and 3D VMAT for stereotactic body radiation therapy in lung.
Chin E; Loewen SK; Nichol A; Otto K
Phys Med Biol; 2013 Feb; 58(4):749-70. PubMed ID: 23324560
[TBL] [Abstract][Full Text] [Related]
14. Conformal and stereotactic radiotherapy in hepatocellular carcinoma.
Scorsetti M; Bignardi M
Ann Ital Chir; 2008; 79(2):107-10. PubMed ID: 18727272
[TBL] [Abstract][Full Text] [Related]
15. Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy.
Wang WJ; Chiou JF; Huang Y
J Vis Exp; 2018 May; (135):. PubMed ID: 29806826
[TBL] [Abstract][Full Text] [Related]
16. Adaptive liver stereotactic body radiation therapy: automated daily plan reoptimization prevents dose delivery degradation caused by anatomy deformations.
Leinders SM; Breedveld S; Méndez Romero A; Schaart D; Seppenwoolde Y; Heijmen BJ
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1016-21. PubMed ID: 24071500
[TBL] [Abstract][Full Text] [Related]
17. Estimate of normal tissue damage in treatment planning for stereotactic radiotherapy.
Benassi M; Begnozzi L; Gentile FP; Chiatti L; Carpino S
Strahlenther Onkol; 1993 Oct; 169(10):612-6. PubMed ID: 8235986
[TBL] [Abstract][Full Text] [Related]
18. Three-dimensional heart dose reconstruction to estimate normal tissue complication probability after breast irradiation using portal dosimetry.
Louwe RJ; Wendling M; van Herk MB; Mijnheer BJ
Med Phys; 2007 Apr; 34(4):1354-63. PubMed ID: 17500466
[TBL] [Abstract][Full Text] [Related]
19. Dosimetric comparison of lung stereotactic body radiotherapy treatment plans using averaged computed tomography and end-exhalation computed tomography images: Evaluation of the effect of different dose-calculation algorithms and prescription methods.
Mitsuyoshi T; Nakamura M; Matsuo Y; Ueki N; Nakamura A; Iizuka Y; Mampuya WA; Mizowaki T; Hiraoka M
Med Dosim; 2016 Winter; 41(4):305-309. PubMed ID: 27623737
[TBL] [Abstract][Full Text] [Related]
20. Multicentre treatment planning inter-comparison in a national context: The liver stereotactic ablative radiotherapy case.
Esposito M; Maggi G; Marino C; Bottalico L; Cagni E; Carbonini C; Casale M; Clemente S; D'Alesio V; Fedele D; Giglioli FR; Landoni V; Martinotti A; Nigro R; Strigari L; Villaggi E; Mancosu P
Phys Med; 2016 Jan; 32(1):277-83. PubMed ID: 26498378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
